Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.


Jan 13, 2022
AHA letter to Reps. Tom Cole, R-Okla., Markwayne Mullin, R-Okla., and Dina Titus, D-Nev., and Sens. Jim Inhofe, R-Okla., and Jacky Rosen, D-Nev, expressing support for the Medical Student Education Authorization Act.
Jan 11, 2022
January 11, 2022 Michael Chernew, Ph.D. Chairman Medicare Payment Advisory Commission 425 I Street, N.W., Suite 701Washington, DC 20001 Dear Dr. Chernew:
Jan 11, 2022
January 11, 2022  President Joseph R. Biden  The White House  1600 Pennsylvania Avenue, N.W. Washington, DC 20500  Dear President Biden:
Jan 11, 2022
January 11, 2022 The Honorable Xavier Becerra Secretary U.S. Department of Health and Human Services 200 Independence Avenue, S.W. Washington, D.C. 20201
Jan 4, 2022
Letter to CMS with comments on the agency’s interim final rule for a mandatory COVID-19 vaccination policy for hospitals and other Medicare/Medicaid participants.
Dec 17, 2021
The SUNSET rule set expiration dates for the vast majority of HHS regulations unless certain conditions are met. Specifically, the department must conduct a review of most of its regulations at certain intervals and then determine whether they should retain, modify, or eliminate the regulation.
Dec 15, 2021
Responding to a recent request for input from the field, the AHA yesterday urged the Center for Medicare and Medicaid Innovation to balance the risk and reward in its alternative payment models “in a way that reflects the significant investments required to launch and maintain APM participation.”
Dec 6, 2021
AHA today strongly urged the departments of Health and Human Services, Labor and Treasury and Office of Personnel Management to restore the independence of the independent dispute resolution process in the No Surprises Act Part 2 regulations.
Dec 6, 2021
The AHA today submitted comments on the Food and Drug Administration’s revised draft guidance on hospital and health system compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act.
Dec 2, 2021
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations; our clinician partners — including more than 270,000 affiliated physicians, 2 million nurses and